TOI

Oncology Institute (TOI)

Oncology Institute Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TOI

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	21 : 00	GlobeNewswire Inc.	The Oncology Institute to Participate at Upcoming Investor Conferences	NASDAQ:TOI	Oncology Institute Inc
2024/05/22	21 : 00	GlobeNewswire Inc.	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference	NASDAQ:TOI	Oncology Institute Inc
2024/05/15	05 : 05	GlobeNewswire Inc.	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance	NASDAQ:TOI	Oncology Institute Inc
2024/05/08	05 : 05	GlobeNewswire Inc.	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit	NASDAQ:TOI	Oncology Institute Inc
2024/04/23	21 : 00	GlobeNewswire Inc.	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
2024/04/08	21 : 00	GlobeNewswire Inc.	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute	NASDAQ:TOI	Oncology Institute Inc
2024/04/04	21 : 00	GlobeNewswire Inc.	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California	NASDAQ:TOI	Oncology Institute Inc
2024/03/28	05 : 05	GlobeNewswire Inc.	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024	NASDAQ:TOI	Oncology Institute Inc
2024/03/14	21 : 09	GlobeNewswire Inc.	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership	NASDAQ:TOI	Oncology Institute Inc
2024/03/06	22 : 00	GlobeNewswire Inc.	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
2024/02/28	06 : 05	GlobeNewswire Inc.	The Oncology Institute to Participate at Upcoming Investor Conferences	NASDAQ:TOI	Oncology Institute Inc
2024/02/20	22 : 00	GlobeNewswire Inc.	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model	NASDAQ:TOI	Oncology Institute Inc
2024/01/25	22 : 00	GlobeNewswire Inc.	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio	NASDAQ:TOI	Oncology Institute Inc
2024/01/20	06 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TOI	Oncology Institute Inc
2023/12/29	07 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/12/29	07 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/12/29	07 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/12/05	09 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/12/04	22 : 00	GlobeNewswire Inc.	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California	NASDAQ:TOI	Oncology Institute Inc
2023/11/23	11 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/23	10 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/23	10 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/22	09 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/18	07 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/17	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/17	05 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/16	08 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/14	07 : 17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TOI	Oncology Institute Inc
2023/11/09	06 : 43	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TOI	Oncology Institute Inc
2023/11/09	06 : 41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TOI	Oncology Institute Inc